SEC Filings for NeuroBo Pharmaceuticals Inc. (NRBO)

$ 13.22   0.05 (+0.38%) Volume: 44.74k 4:00 PM EDT 29-May-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)705/26/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)4205/20/2020
NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB305/18/2020
DEF 14AOther definitive proxy statements3704/29/2020
424B5Prospectus [Rule 424(b)(5)]5904/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)6504/15/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans1304/01/2020
8-KCurrent report pursuant to Section 13 or 15(d)1103/30/2020
10-KAnnual report pursuant to Section 13 or 15(d)23303/30/2020
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)802/20/2020
SC 13GStatement of acquisition of beneficial ownership by individuals402/13/2020
8-KCurrent report pursuant to Section 13 or 15(d)2302/13/2020
8-KCurrent report pursuant to Section 13 or 15(d)402/04/2020
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)3201/22/2020
3/A[Amend] Initial statement of beneficial ownership of securities201/17/2020
<<
First
<
Prev
123456789101112131415